Markets do not always move in straight lines.
Even high-quality businesses can see their share prices drift lower during periods of uncertainty. For long-term investors, those moments can create opportunities to accumulate blue chip ASX shares at more attractive levels.
Here are three quality names I would be comfortable buying now.
ResMed Inc. (ASX: RMD)
The first blue chip ASX share I would consider buying is ResMed.
ResMed is a global leader in sleep disorder treatments. Its devices and cloud-connected software help millions of patients manage conditions such as sleep apnoea and chronic obstructive pulmonary disease.
But the company is still only scratching at the surface of its market opportunity. Management estimates that there are over 1 billion sufferers of sleep apnoea globally. However, the majority of these people don’t know they have the condition.
As awareness grows, ResMed stands to benefit greatly as the clear market leader.
In addition, the company has been investing in digital health platforms that link devices to data, improving patient outcomes and strengthening recurring revenue streams. Combined, this blue chip appears well-placed to continue its growth over the next decade and beyond.
Macquarie Group Ltd (ASX: MQG)
Another blue chip ASX share worth a look is Macquarie Group.
Macquarie has built a global reputation in infrastructure, asset management, and specialist financial services. It benefits from exposure to long-term trends such as renewable energy, digital infrastructure, and alternative assets.
Unlike traditional banks, Macquarie’s earnings are more diversified across geographies and business lines. This can provide resilience across economic cycles.
With strong capital management and a track record of reinvesting into growth areas, Macquarie remains one of the more dynamic blue-chip names on the ASX.
Wesfarmers Ltd (ASX: WES)
A final blue chip ASX share I would consider this week is Wesfarmers.
It owns businesses such as Bunnings, Kmart, Target, Priceline, Silk Laser, WesCEF, and Officeworks. These are well-known brands with significant scale advantages in their respective markets.
Bunnings in particular has demonstrated pricing power and operational discipline over many years. Meanwhile, Wesfarmers continues to invest in growth areas, including lithium and health, while maintaining a strong balance sheet.
The company’s combination of retail leadership, capital allocation discipline, and diversification could make it a reliable long-term holding.
The post Why I would buy ResMed and these quality blue chips now appeared first on The Motley Fool Australia.
Should you invest $1,000 in Macquarie Group Limited right now?
Before you buy Macquarie Group Limited shares, consider this:
Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Macquarie Group Limited wasn’t one of them.
The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*
And right now, Scott thinks there are 5 stocks that may be better buys…
* Returns as of 20 Feb 2026
.custom-cta-button p {
margin-bottom: 0 !important;
}
More reading
- JB Hi-Fi vs. Wesfarmers: Which retail stock deserves a place in your portfolio?
- Aged under 40? Here are 3 financial moves that could set you up for life
- Where to invest $10,000 in ASX 200 shares in March
- Buy Telstra and these ASX dividend stocks for passive income
- Experts name 3 ASX dividend shares to buy
Motley Fool contributor James Mickleboro has positions in ResMed. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Macquarie Group, ResMed, and Wesfarmers. The Motley Fool Australia has positions in and has recommended Macquarie Group and ResMed. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.